EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibroblast‐derived miR ‐425‐5p alleviates cardiac remodelling in heart failure via inhibiting the TGF ‐β1/Smad signalling

Haijia Zhou, Pengyun Liu, Xuelin Guo, Wei Fang, Chan Wu, Mingming Zhang iD, Zhaole Ji iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Haijia Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tangdu Hospital, Second Affiliated Hospital of Air Force Medical University, Xi'an, China. Hauptthemen laut MEDLINE: MicroRNAs, Heart Failure, Signal Transduction, Fibroblasts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathological activation of cardiac fibroblasts (CFs) plays a crucial role in the development of pressure overload‐induced cardiac remodelling and subsequent heart failure (HF). Growing evidence demonstrates that multiple microRNAs (miRNAs) are abnormally expressed in the pathophysiologic process of cardiovascular diseases, with miR‐425 recently reported to be potentially involved in HF. In this study, we aimed to investigate the effects of fibroblast‐derived miR‐425‐5p in pressure overload‐induced HF and explore the underlying mechanisms. C57BL/6 mice were injected with a recombinant adeno‐associated virus specifically designed to overexpress miR‐425‐5p in CFs, followed by transverse aortic constriction (TAC) surgery. Neonatal mouse CFs (NMCFs) were transfected with miR‐425‐5p mimics and subsequently stimulated with angiotensin II (Ang II). We found that miR‐425‐5p levels were significantly downregulated in HF mice and Ang II‐treated NMCFs. Notably, fibroblast‐specific overexpression of miR‐425‐5p markedly inhibited the proliferation and differentiation of CFs, thereby alleviating myocardial fibrosis, cardiac hypertrophy and systolic dysfunction. Mechanistically, the cardioprotective actions of miR‐425‐5p may be achieved by targeting the TGF‐β1/Smad signalling. Interestingly, miR‐425‐5p mimics‐treated CFs could also indirectly affect cardiomyocyte hypertrophy in this course. Together, our findings suggest that fibroblast‐derived miR‐425‐5p mitigates TAC‐induced HF, highlighting miR‐425‐5p as a potential diagnostic and therapeutic target for treating HF patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsHeart FailureSignal TransductionFibroblastsTransforming Growth Factor beta1Smad ProteinsMice, Inbred C57BLAnimalsMiceVentricular RemodelingMaleCell ProliferationAngiotensin IIFibrosisCell DifferentiationCardiomegalyDisease Models, Animal

Stichwörter der Autor:innen

TGF‐β1/Smadcardiac remodellingfibroblastheart failuremiR‐425‐5ptransverse aortic constriction

Substanzen

MicroRNAsTransforming Growth Factor beta1Smad ProteinsAngiotensin II

Autor:innen und Institutionen

  • Department of Cardiology, Tangdu Hospital, Second Affiliated Hospital of Air Force Medical University, Xi'an, China.

ORCID-Profile: Mingming Zhang, Zhaole Ji

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, H., Liu, P., Guo, X., Fang, W., Wu, C., Zhang, M., & Ji, Z. (2024). Fibroblast‐derived miR ‐425‐5p alleviates cardiac remodelling in heart failure via inhibiting the TGF ‐β1/Smad signalling. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70199

Vancouver

Zhou H, Liu P, Guo X, Fang W, Wu C, Zhang M, et al. Fibroblast‐derived miR ‐425‐5p alleviates cardiac remodelling in heart failure via inhibiting the TGF ‐β1/Smad signalling. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70199

BibTeX
@article{Zhou2024,
  author = {Zhou, Haijia and Liu, Pengyun and Guo, Xuelin and Fang, Wei and Wu, Chan and Zhang, Mingming and Ji, Zhaole},
  title = {Fibroblast‐derived miR ‐425‐5p alleviates cardiac remodelling in heart failure via inhibiting the TGF ‐β1/Smad signalling},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70199}
}
Kostenlos starten →